LNCaP/iRFP cells are derived from the human prostate cancer LNCaP cell line by stably integration of a constitutive miRFP670 stably expression construct. LNCaP cells are androgen-sensitive, making them valuable for studying prostate cancer biology and testing potential treatments related to hormone regulation. LNCaP/iRFP cells stably express miRFP670, can be used for in vitro assays and in vivo imaging.
